Impact of Cytidine Deaminase Polymorphisms on Toxicity After Gemcitabine: The Question Is Still Ongoing

E. Giovannetti, C. Tibaldi, A. Falcone, R. Danesi, G.J. Peters

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)E221-E222
JournalJournal of Clinical Oncology
Volume28
Issue number14
DOIs
Publication statusPublished - 2010

Cite this

@article{e9a7ff2629ee483d8b0eda60c60578f4,
title = "Impact of Cytidine Deaminase Polymorphisms on Toxicity After Gemcitabine: The Question Is Still Ongoing",
author = "E. Giovannetti and C. Tibaldi and A. Falcone and R. Danesi and G.J. Peters",
year = "2010",
doi = "10.1200/JCO.2009.27.4928",
language = "Undefined/Unknown",
volume = "28",
pages = "E221--E222",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "14",

}

Impact of Cytidine Deaminase Polymorphisms on Toxicity After Gemcitabine: The Question Is Still Ongoing. / Giovannetti, E.; Tibaldi, C.; Falcone, A.; Danesi, R.; Peters, G.J.

In: Journal of Clinical Oncology, Vol. 28, No. 14, 2010, p. E221-E222.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Impact of Cytidine Deaminase Polymorphisms on Toxicity After Gemcitabine: The Question Is Still Ongoing

AU - Giovannetti, E.

AU - Tibaldi, C.

AU - Falcone, A.

AU - Danesi, R.

AU - Peters, G.J.

PY - 2010

Y1 - 2010

U2 - 10.1200/JCO.2009.27.4928

DO - 10.1200/JCO.2009.27.4928

M3 - Article

VL - 28

SP - E221-E222

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 14

ER -